Trials / Conditions / Depressive Disorder and Anxiety Disorders

Depressive Disorder and Anxiety Disorders

11 registered clinical trials studyying Depressive Disorder and Anxiety Disorders — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	The Impact of Melatonin Lotion on Sleep and Mental Health NCT06768749	University of Redlands	N/A
Completed	First Time in Human Study NCT01031186	GlaxoSmithKline	Phase 1
Completed	Emotional Processing in Healthy Volunteers in the Presence of an Investigational Anxiolytic NCT01424384	GlaxoSmithKline	Phase 1
Completed	A First Time in Human Study of GSK586529 in Healthy Volunteers NCT00703547	GlaxoSmithKline	Phase 1
Completed	Relative Bioavailability and Food Effect Study for GSK163090 in Healthy Male and Female Volunteers NCT00536679	GlaxoSmithKline	Phase 1
Completed	A Study To Investigate Effects Of GSK561679 On Brain Activation During Emotional Processing In Healthy Volunte NCT00513565	GlaxoSmithKline	Phase 1
Completed	Study Of Safety, Blood Levels, And Brain Receptor Occupancy Of GSK163090 Using PET Imaging In Healthy Males NCT00435695	GlaxoSmithKline	Phase 1
Completed	To Investigate Effects GSK561679 on Part of the Body's System That Controls the Balance of Many of the Hormone NCT00426608	GlaxoSmithKline	Phase 1
Completed	First Study in Humans With GSK424887 NCT01059591	GlaxoSmithKline	Phase 1
Completed	First Study in Humans With GSK206136 NCT01059578	GlaxoSmithKline	Phase 1
Completed	PET (Positron Emission Tomography)/Public Speaking Study With A Combination Of 2 Medications In Social Anxiety NCT00343707	GlaxoSmithKline	Phase 2